Joseph Anderson
Director/Board Member at AUTOLUS THERAPEUTICS PLC
Net worth: - $ as of 2024-04-29
Network origin in Joseph Anderson first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco.
41
| Private Company | Investment Managers | 41 |
| Public Company | Biotechnology | 32 | |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 15 | |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Cytos Biotechnology AG engages in the development and commercialization of biopharmaceutical products. The company was founded by Wolfgang A. Renner, James E. Bailey and Hans M. Eppenberger in February 1995 and is headquartered in Zurich, Switzerland.
12
| Extinct | Miscellaneous Commercial Services | 12 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom.
10
| Subsidiary | Biotechnology | 10 |
| Extinct | Pharmaceuticals: Major | 8 | |
Abingworth Management Ltd.
 Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom.
7
| Private Company | Investment Managers | 7 |
| Public Company | Medical Specialties | 5 | |
Arix Bioscience /Venture Capital/
 Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York.
3
| Subsidiary | Investment Managers | 3 |
The Wellcome Trust Ltd.
 The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK.
3
| Foundation/Endowment | Investment Trusts/Mutual Funds | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joseph Anderson via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| IMMUNOMEDICS, INC. | Biotechnology | Sales & Marketing Chief Tech/Sci/R&D Officer Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | President Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| ACUSPHERE, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
| ACCELERON PHARMA INC. | Biotechnology | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Director/Board Member Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University College Dublin | College/University | Masters Business Admin Undergraduate Degree | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member General Counsel | |
| University College London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Doctorate Degree | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Chief Administrative Officer Chief Executive Officer Director/Board Member Director of Finance/CFO General Counsel | |
France Biotech Association
 France Biotech Association Miscellaneous Commercial ServicesCommercial Services France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin. | Miscellaneous Commercial Services | Founder Director/Board Member | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
MD Start SA
 MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Biotechnology | Chairman Director/Board Member Chief Investment Officer | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Amarin Pharma, Inc.
 Amarin Pharma, Inc. Pharmaceuticals: MajorHealth Technology Amarin Pharma, Inc. operates as a biopharmaceutical research company. The company was founded in 2007 and is headquartered in Bedminster, NJ. | Pharmaceuticals: Major | Corporate Secretary Chief Executive Officer | |
HighLife SAS
 HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Synthace Ltd.
 Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Packaged Software | Director/Board Member Director/Board Member | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Kesios Therapeutics Ltd.
 Kesios Therapeutics Ltd. BiotechnologyHealth Technology Kesios Therapeutics Ltd. provides biotechnology services. It develops novel therapeutics for the treatment of multiple myeloma and other cancers where there are significant unmet medical needs. The company was founded by Menotti Ruvo, Laura Tornatore, and Guido Franzoso on July 13, 2012 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| AFYREN | Biotechnology | Director/Board Member Director/Board Member | |
LimFlow SA
 LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Founder Director/Board Member Director/Board Member | |
SafeHeal SAS
 SafeHeal SAS Medical SpecialtiesHealth Technology SafeHeal SAS develops anastomosis protection devices for improved patient recovery and reduced healthcare costs. The company is headquartered in Paris, France. | Medical Specialties | Chairman Director/Board Member President | |
Abingworth Bioventures GP Ltd.
 Abingworth Bioventures GP Ltd. Other TransportationTransportation Abingworth Bioventures GP Ltd. provides marine cargo handling facilities. The company was founded on March 29, 2012 and is headquartered in London, the United Kingdom. | Other Transportation | Director/Board Member Director/Board Member Director/Board Member | |
May Health SAS
 May Health SAS Miscellaneous Commercial ServicesCommercial Services May Health SAS engages in the development of device for the treatment of polycystic ovary syndrome infertility. The company was founded in September 2017 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Chairman Chairman Director/Board Member President | |
Moon Surgical SAS
 Moon Surgical SAS Medical SpecialtiesHealth Technology Moon Surgical SAS is a French medical technology company that is creating a new category of robotic surgery. The company is based in Paris, France and is operated by renowned serial medical innovators and backed by leading venture capitalists. Its Maestro system enhances existing laparoscopic techniques and tools with new capabilities, benefiting the 93%% of patients who currently do not have access to minimally invasive robotic surgery. The CEO of the company is Anne Osdoit. | Medical Specialties | Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer | |
| New York University School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
Comet Biorefining, Inc.
 Comet Biorefining, Inc. BiotechnologyHealth Technology Comet Biorefining, Inc. operates as a holding company, which engages in the provision of cellulosic glucose technology for applications in renewable biofuels and biochemicals. It proprietary technology allows for the conversion of wood, wheat straw, bagasse, corn stover and other agricultural waste materials into high purity cellulosic glucose syrup. These non-food sources offer lower cost and price stability when compared to food sugar sources such as corn or sugar cane. The company was founded by Andrew Richard in 2009 and is headquartered in London, Canada. | Biotechnology | Director/Board Member Director/Board Member |
Statistics
International
| United States | 21 |
| United Kingdom | 12 |
| France | 12 |
| Switzerland | 4 |
| Ireland | 3 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 2 |
Operational
| Director/Board Member | 714 |
| Corporate Officer/Principal | 174 |
| Chairman | 165 |
| Independent Dir/Board Member | 142 |
| Undergraduate Degree | 67 |
Most connected contacts
| Insiders | |
|---|---|
| Christopher Evans | 62 |
| Carl Gordon | 59 |
| Antoine Papiernik | 48 |
| John Johnson | 40 |
| Kapil Dhingra | 39 |
| Joshua Makower | 37 |
| Timothy Haines | 36 |
| Kurt von Emster | 34 |
| Thomas Gerard Lynch | 34 |
| Martin Murphy | 33 |
| William Young | 32 |
| Joseph Zakrzewski | 30 |
| David Stack | 27 |
| Denis Lucquin | 26 |
| Maina Bhaman | 26 |
- Stock Market
- Insiders
- Joseph Anderson
- Company connections